Evoke Pharma and QOL Medical Announce Expiration of Tender Offer
Evoke Stockholders Received $11.00 Per Share in Cash Evoke Pharma, Inc.(formerly NASDAQ: EVOK) (“Evoke”) and QOL Medical, LLC (“QOL Medical”)today announced that the tender offer (the “Offer”) by QOL-EOS Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of QOL Medical (the “Merger Sub”), to acquire all of the outstanding shares of […]